Eli Lilly to buy Scorpion Therapeuticsâ cancer drug for $2.5 billion
Eli Lilly and Company will acquire Scorpion Therapeuticsâ investigational cancer drug, currently being evaluated in first- mid-stage trials to treat breast and solid.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Eli Lilly and Company will acquire Scorpion Therapeuticsâ investigational cancer drug, currently being evaluated in first- mid-stage trials to treat breast and solid.
Johnson & Johnson will acquire Intra-Cellular Therapies Inc., a biopharmaceutical company developing drugs for central nervous system disorders, for $14.6 billion, according to.
Bharti Jayshankar January 11, 2024: Excessive screen time of children is a growing concern as many studies have correlated cognitive and language skills.
Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of.
Pizer Inc.âs late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained.
ohnson & Johnson paused its rollout of a heart device to treat atrial fibrillation âout of an abundance of caution,â as it probes four.
HQ Team January 10, 2024: The global health burden of sugary drinks has reached alarming levels, with a new study published in Nature.
China has approved Merck & Co.âs human papillomavirus vaccine for males between nine and 26 years amid a fall in sales for the.
Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs.
China will develop humanoid robots for elderly care and support scientific and technological projects related to senior citizens, according to a state-run news.